Covered recipient · General Payments record
MAUSHMI N SHETH
Allopathic & Osteopathic Physicians Psychiatry & Neurology Clinical Neurophysiology
General Payments · PY2018–2024
$10,344.34
- Reported across 449 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,042.15 | 34 |
| Education | $16.72 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $312.16 | 5 |
| ABBVIE INC. | $226.60 | 13 |
| Grifols USA, LLC | $163.23 | 1 |
| ACADIA Pharmaceuticals Inc | $93.94 | 4 |
| Celgene Corporation | $70.42 | 4 |
| Biogen, Inc. | $49.25 | 2 |
| EMD Serono, Inc. | $32.17 | 1 |
| Averitas Pharma Inc. | $29.56 | 1 |
| SK Life Science, Inc. | $25.39 | 1 |
| Kedrion Biopharma, Inc. | $23.57 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
| Kyowa Kirin, Inc. | $15.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.56 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085472 | CMS |
| ABBVIE INC. | $17.09 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085474 | CMS |
| ABBVIE INC. | $19.89 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085476 | CMS |
| ABBVIE INC. | $27.99 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085478 | CMS |
| ABBVIE INC. | $19.97 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085480 | CMS |
| ABBVIE INC. | $13.37 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085482 | CMS |
| ABBVIE INC. | $6.82 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085484 | CMS |
| ABBVIE INC. | $19.38 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085486 | CMS |
| ABBVIE INC. | $12.28 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085488 | CMS |
| ABBVIE INC. | $1.39 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085490 | CMS |
| ABBVIE INC. | $22.96 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085492 | CMS |
| ABBVIE INC. | $30.38 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085494 | CMS |
| ABBVIE INC. | $15.52 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106085496 | CMS |
| ACADIA Pharmaceuticals Inc | $26.67 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147993346 | CMS |
| ACADIA Pharmaceuticals Inc | $27.48 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147993350 | CMS |
| ACADIA Pharmaceuticals Inc | $25.29 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147993354 | CMS |
| ACADIA Pharmaceuticals Inc | $14.50 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147993358 | CMS |
| Amgen Inc. | $18.34 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116117981 | CMS |
| Amgen Inc. | $130.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116117987 | CMS |
| Amgen Inc. | $130.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116117993 | CMS |
| Amgen Inc. | $15.73 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116117999 | CMS |
| Amgen Inc. | $17.89 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116118007 | CMS |
| Averitas Pharma Inc. | $29.56 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133446106 | CMS |
| Biogen, Inc. | $20.90 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104805489 | CMS |
| Biogen, Inc. | $28.35 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104812197 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 10/29/2024 | Education | Undisputed | 01/23/2026 | 1144456028 | CMS |
| Celgene Corporation | $20.39 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101188337 | CMS |
| Celgene Corporation | $15.05 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101188339 | CMS |
| Celgene Corporation | $16.74 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101188365 | CMS |
| Celgene Corporation | $18.24 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101188375 | CMS |
| EMD Serono, Inc. | $32.17 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120237640 | CMS |
| Grifols USA, LLC | $163.23 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124735805 | CMS |
| Kedrion Biopharma, Inc. | $23.57 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125860799 | CMS |
| Kyowa Kirin, Inc. | $15.86 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127037194 | CMS |
| SK Life Science, Inc. | $25.39 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154146318 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.